BioArctic AB (publ)
BRCTF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.69 | -0.46 | -0.00 | -2.23 |
| FCF Yield | -0.16% | 7.10% | 0.07% | -0.15% |
| EV / EBITDA | -16,486.26 | 81.34 | 14.42 | -402.87 |
| Quality | ||||
| ROIC | 3.52% | 4.83% | 51.91% | -4.04% |
| Gross Margin | 90.84% | 94.77% | 99.11% | 88.30% |
| Cash Conversion Ratio | 1.43 | 6.41 | 0.01 | 0.51 |
| Growth | ||||
| Revenue 3-Year CAGR | 43.59% | 44.49% | 34.91% | 4.07% |
| Free Cash Flow Growth | -103.59% | 9,630.53% | 143.08% | 65.90% |
| Safety | ||||
| Net Debt / EBITDA | 70.99 | -4.79 | -0.47 | 10.61 |
| Interest Coverage | -9.28 | 11.14 | 75.54 | -81.18 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -1,484.10 | -69.51 | 0.00 | -319.93 |